Probiotics for Lowering Blood Pressure in Chinese Adults
Part of Heart & circulation clinical trials.
This study tests whether a probiotic supplement (Bifidobacterium) can help lower blood pressure in middle-aged Chinese adults with mild to moderate hypertension. You may qualify if you are not currently on blood pressure medication and have no other major health problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 65 years old.
- You are Chinese and live in Hong Kong.
- Your systolic blood pressure (top number) is between 130 and 165 mmHg at the screening visit.
- You have not taken any blood pressure medications in the last 4 weeks.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have serious health conditions like diabetes, heart disease, or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking prebiotics can help manage blood pressure in adults newly diagnosed with hypertension. It may be useful if you are not already on blood pressure medicines and your blood pressure is in the high range.
This study tests whether a special diet can lower blood pressure. If you work at Shengli Oilfield, eat at the workplace canteen, and have high blood pressure, you may be able to join a program that provides meals designed to help manage your condition.
This study tests if a probiotic supplement can help your body turn nitrates from food into a substance that may improve blood flow. Healthy adults who are comfortable with blood and saliva samples can take part.
This trial tests if a pharmacist-led program with regular follow-ups and support can help people with high blood pressure get better control over their condition. It may be a good fit if you have high blood pressure that is not well controlled despite taking medication.
This early-stage study tests a new medication called IBI3016 to help lower blood pressure in people with mild to moderate hypertension who haven't recently taken blood pressure medications. The goal is to see if this drug is safe and effective.
This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.